Marked Sinus Bradycardia Associated With Remdesivir in COVID-19
Remdesivir has seen extensive use during the coronavirus disease-2019 pandemic given its clinically proven efficacy against severe acute respiratory syndrome coronavirus type 2. There has been little cited regarding adverse effects. Here we present the case of a patient with marked sinus bradycardia...
Main Authors: | James C. Gubitosa, DO, Parul Kakar, MD, Christine Gerula, MD, Hernando Nossa, MD, Diana Finkel, MD, Kristin Wong, MD, Megna Khatri, MD, Hasan Ali, DO |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | JACC: Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666084920311001 |
Similar Items
-
Remdesivir-induced symptomatic bradycardia in the treatment of COVID-19 disease
by: Jomel Patrick Jacinto, DO, et al.
Published: (2021-08-01) -
Sinus Node Dysfunction in a Young Patient With COVID-19
by: Giuliana Cimino, MD, et al.
Published: (2020-07-01) -
Intermittent Loss of Telemetry Data
by: Dimitrios Katsaras, MD, et al.
Published: (2021-01-01) -
Junctional bradycardia caused by subarachnoid hemorrhage
by: Wei-Hsiang Liao, et al.
Published: (2021-03-01) -
Permanent pacemaker implantation in unexplained syncope patients with borderline sinus bradycardia and electrophysiology study‐proven sinus node disease
by: Ioannis Doundoulakis, et al.
Published: (2021-02-01)